Your browser doesn't support javascript.
loading
Prospective application of the risk analysis index to measure preoperative frailty in spinal tumor surgery: A single center outcomes analysis.
Link, Remy L; Rumalla, Kavelin; Courville, Evan N; Roy, Joanna M; Faraz Kazim, Syed; Bowers, Christian A; Schmidt, Meic H.
Afiliação
  • Link RL; Department of Neurosurgery, University of New Mexico Hospital (UNMH), Albuquerque, NM, USA.
  • Rumalla K; Department of Neurosurgery, University of New Mexico Hospital (UNMH), Albuquerque, NM, USA.
  • Courville EN; Bowers Neurosurgical Frailty and Outcomes Data Science Lab, Albuquerque, NM, 87131, USA.
  • Roy JM; Department of Neurosurgery, University of New Mexico Hospital (UNMH), Albuquerque, NM, USA.
  • Faraz Kazim S; Bowers Neurosurgical Frailty and Outcomes Data Science Lab, Albuquerque, NM, 87131, USA.
  • Bowers CA; Bowers Neurosurgical Frailty and Outcomes Data Science Lab, Albuquerque, NM, 87131, USA.
  • Schmidt MH; Topiwala National Medical College, Mumbai, India.
World Neurosurg X ; 19: 100203, 2023 Jul.
Article em En | MEDLINE | ID: mdl-37181582
ABSTRACT

Introduction:

Surgeons are frequently faced with challenging clinical dilemmas evaluating whether the benefits of surgery outweigh the substantial risks routinely encountered with spinal tumor surgery. The Clinical Risk Analysis Index (RAI-C) is a robust frailty tool administered via a patient-friendly questionnaire that strives to augment preoperative risk stratification. The objective of the study was to prospectively measure frailty with RAI-C and track postoperative outcomes after spinal tumor surgery.

Methods:

Patients surgically treated for spinal tumors were followed prospectively from 7/2020-7/2022 at a single tertiary center. RAI-C was ascertained during preoperative visits and verified by the provider. The RAI-C scores were assessed in relation to postoperative functional status (measured by modified Rankin Scale score [mRS]) at the last follow-up visit.

Results:

Of 39 patients, 47% were robust (RAI 0-20), 26% normal (21-30), 16% frail (31-40), and 11% severely frail (RAI 41+).). Pathology included primary (59%) and metastatic (41%) tumors with corresponding mRS>2 rates of 17% and 38%, respectively. Tumors were classified as extradural (49%), intradural extramedullary (46%), or intradural intramedullary (5.4%) with mRS>2 rates of 28%, 24%, and 50%, respectively. RAI-C had a positive association with mRS>2 â€‹at follow-up 16% for robust, 20% for normal, 43% for frail, and 67% for severely frail. The two deaths in the series had the highest RAI-C scores (45 and 46) and were patients with metastatic cancer. The RAI-C was a robust and diagnostically accurate predictor of mRS>2 in receiver operating characteristic curve analysis (C-statistic 0.70, 95 CI 0.49-0.90).

Conclusions:

The findings exemplify the clinical utility of RAI-C frailty scoring for prediction of outcomes after spinal tumor surgery and it has potential to help in the surgical decision-making process as well as surgical consent. As a preliminary case series, the authors intend to provide additional data with a larger sample size and longer follow-up duration in a future study.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article